首页> 外文期刊>European journal of human genetics: EJHG >Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes.
【24h】

Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes.

机译:肝素后脂肪酶检测对检测LPL和LIPC基因的常见遗传变异的诊断价值。

获取原文
获取原文并翻译 | 示例
           

摘要

Post-heparin lipoprotein lipase and hepatic lipase activities are used to identify primary disorders of triglyceride and HDL-cholesterol metabolism. Their ability to identify common variants in the lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes is unclear. To investigate the ability of lipase testing to detect common lipase gene variants, we included 183 patients who had undergone post-heparin lipase testing and genotyped the LPL D9N, N291S, PvuII, HindIII, and S447X and the LIPC-514CT, V73M, V133V, and N193S polymorphisms. Allele frequencies were compared with 163 controls. Polymorphisms with different allele frequencies in patients and controls or influencing lipids, were analyzed further. The diagnostic value of post-heparin lipase testing was assessed using logistic regression and receiver operating characteristic curves. We found that lipase activities did not predict the LPL D9N and N291S polymorphisms, but predicted the LPL S447X and LIPC-514CT polymorphisms. Adjusted for covariates, the area under the receiver operating characteristic curves was 0.643, 0.478, 0.686, and 0.657 for LPL D9N, N291S S447X and LIPC-514CT, respectively. On the basis of these findings, we conclude that high-LPL and low-HL activities associate with the LPL S447X and LIPC-514CT polymorphisms, but low-LPL activity was not related to LPL polymorphisms. Overall, the discriminative ability of post-heparin lipase tests in identifying carriers of common variants in the LPL and LIPC genes was limited. This indicates that conclusions on the genetic causes of lipase activities outside of the normal range should be drawn with caution.
机译:肝素后脂蛋白脂肪酶和肝脂肪酶活性用于鉴定甘油三酸酯和HDL-胆固醇代谢的主要疾病。他们鉴定脂蛋白脂肪酶(LPL)和肝脂肪酶(LIPC)基因常见变异的能力尚不清楚。为了研究脂肪酶测试检测常见脂肪酶基因变异的能力,我们纳入了183位接受肝素后脂肪酶测试并且对LPL D9N,N291S,PvuII,HindIII和S447X以及LIPC-514CT,V73M,V133V,和N193S多态性。将等位基因频率与163个对照进行比较。进一步分析了患者和对照中或影响脂质的等位基因频率不同的多态性。肝素后脂肪酶检测的诊断价值通过逻辑回归和受试者工作特征曲线进行评估。我们发现,脂肪酶活性不能预测LPL D9N和N291S多态性,但可以预测LPL S447X和LIPC-514CT多态性。调整协变量后,LPL D9N,N291S S447X和LIPC-514CT的接收机工作特性曲线下的面积分别为0.643、0.478、0.686和0.657。根据这些发现,我们得出结论,高LPL和低HL活性与LPL S447X和LIPC-514CT多态性相关,但低LPL活性与LPL多态性无关。总体而言,肝素后脂肪酶测试在识别LPL和LIPC基因常见变异携带者方面的区分能力有限。这表明应谨慎得出关于脂肪酶活性超出正常范围的遗传原因的结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号